A research team from the Stony Brook Cancer Center found a novel therapeutic that is shown to be highly effective in reducing non-small cell lung cancer tumors.
An SBU-led study published in Cellular and Molecular Gastroenterology and Hepatology unravels how dietary protein sources mediate colitis pathogenesis.
Stony Brook pathology researcher’s work supported by a $2.6M NIH grant There is currently no effective drug to treat a hemorrhagic stroke when a ruptured blood vessel causes bleeding into the brain. However, Researcher...
Sui Zee, MD, vice chair for Anatomic Pathology and director of Surgical Pathology at the Stony Brook University Renaissance School of Medicine, was featured in Q&A about diversity in healthcare.